BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• FDA

  Chembio Diagnostics, Inc.'s HIV 1/2 STAT-PAK(R) Assay Receives CE Mark Approval For Rapid Point-Of-Care Detection Of HIV

  March 26, 2014

   · 

  1 min read
• Deals

  MediWound Announces Closing Of Initial Public Offering

  March 26, 2014

   · 

  1 min read
• Drug Development

  AM-Pharma Holding BV Announces Positive Phase I Data On recAP, For Acute Kidney Injury

  March 26, 2014

   · 

  1 min read
• Global Partners SillaJen, TRANSGENE And TRANSGENE Confirm Clinical Development Plan For Pexa-Vec

  March 26, 2014

   · 

  1 min read
• Drug Development

  e-Therapeutics plc Announces Recruitment Resumes Into UK Phase I ETS2101 Cancer Trial

  March 26, 2014

   · 

  1 min read
• FDA

  Nuvolase Inc. Receives TGA Clearance To Market The Pinpointe™ Footlaser™ In Australia

  March 26, 2014

   · 

  1 min read
• Business

  Thermo Fisher Scientific And Harvard University Release: Industry-Academic Collaboration Targets Major Proteomics Quantitation Advances

  March 26, 2014

   · 

  1 min read
• Lone Star Bio

  SwRI Awarded An HHS $8.3 Million Contract Extension For Continued Development Of Cyanide Antidote

  March 26, 2014

   · 

  1 min read
• Pharm Country

  Pfizer Inc. Invites Public To View And Listen To Webcast Of May 5 Conference Call With Analysts

  March 26, 2014

   · 

  1 min read
• Genetown

  Dyax Corp. Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares

  March 26, 2014

   · 

  1 min read